Directory
>
Emile Farhan
Emile Farhan
Retired Pharmaceutical Executive | AVEO Oncology
Cambridge, Massachusetts, United States
Emile Farhan
Summary
Emile Farhan is a seasoned pharmaceutical executive with extensive experience in technical operations and drug development. Currently serving as the Senior Vice President at AVEO Oncology, he has a strong background in regulatory affairs and project management within the biopharmaceutical sector. With a Ph.D. in Organic Chemistry from Brandeis University, Emile has held several leadership roles in various companies, demonstrating a consistent trajectory of growth and expertise in the industry. His work spans across multiple facets of pharmaceutical development, including commercialization and clinical trials. Emile's career reflects a commitment to advancing oncology treatments and improving patient outcomes. He has a deep understanding of compliance with FDA regulations and has successfully led teams through complex drug development processes. Beyond his professional achievements, he has a passion for mentoring emerging leaders in the life sciences field.
Emile Farhan
Work Experience
Retired Pharmaceutical Executive at
Self-Employed
January 2023 - Present
Senior Vice President, Technical Operations at
AVEO Oncology
January 2013 - Present
Senior Director at
AVEO Oncology
April 2012 - December 2012
CMC Drug Development Consultant at
Cmc Drug Development Consulting
May 2011 - March 2012
Director, CMC Global Operations Coordination at
Eisai US
January 2008 - May 2011
Director, Pharmaceutical Development at
MGI Pharma GmbH
January 2007 - January 2008
Sr. Director at
Mersana Therapeutics
January 2007 - January 2007
Senior Director, Scientific Operations at
Johnson Matthey Pharma Services Inc.
January 2000 - January 2006
Director, Chemical Development at
Pharm Eco
January 1992 - January 2000
Emile Farhan
Education
Brandeis University, Ph.D.
January 1988 - January 1992
Brandeis University, Ph.D.
January 1988 - January 1992
Frequently Asked Questions about Emile Farhan
What is Emile Farhan email address?
Emile Farhan's primary email address is ************@eisai.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Emile Farhan work for?
Emile Farhan is a Retired Pharmaceutical Executive at AVEO Oncology, a company specializing in Commercial physical research.
Where Emile Farhan graduated from?
Emile Farhan holds a degree in Organic Chemistry from Brandeis University.
How can I directly contact Emile Farhan?
To contact Emile Farhan directly, you can use the email address ************@eisai.com. Complete contact information is available upon registration with Muraena.
Who is Emile Farhan?
Emile Farhan is a seasoned pharmaceutical executive with extensive experience in technical operations and drug development. Currently serving as the Senior Vice President at AVEO Oncology, he has a strong background in regulatory affairs and project management within the biopharmaceutical sector. With a Ph.D. in Organic Chemistry from Brandeis University, Emile has held several leadership roles in various companies, demonstrating a consistent trajectory of growth and expertise in the industry. His work spans across multiple facets of pharmaceutical development, including commercialization and clinical trials. Emile's career reflects a commitment to advancing oncology treatments and improving patient outcomes. He has a deep understanding of compliance with FDA regulations and has successfully led teams through complex drug development processes. Beyond his professional achievements, he has a passion for mentoring emerging leaders in the life sciences field.
Emile`s contact details
************@eisai.com
*******@aveooncology.com
Colleagues
VP of Technical Operations
Executive Director, Thought Leader Engagement & Strategic Partnerships
Chief Commercial Officer (CCO)
Executive Director, Head Of Trade & Distribution
Board Member
SVP, General Counsel at AVEO Oncology
Vice President of Sales Oncology Hematology
Advisor to CEO
Executive Director, National Accounts and Federal Markets
Executive Director, Head of Medical Affairs